Physician profile
Nancy J Johnson
NPI 1700012697
$584.36
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $197 · 2023: $99.07 · 2024: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $111.07 | 2024 | Hydrofera Blue |
| Pfizer INC. | $83.71 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $83.43 | 2021-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $63.06 | 2021-2023 | Vaxelis, Gardasil 9 |
| Glaxosmithkline, LLC. | $47.43 | 2022-2023 | Trelegy Ellipta, Shingrix, Bexsero |
| Sanofi Pasteur INC. | $35.72 | 2021-2022 | |
| Cranial Technologies, INC | $35.54 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.36 | 2022-2023 | |
| Lilly USA, LLC | $18.50 | 2022 | |
| Lifescan, INC. | $17.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.39 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.08 | 2021 | |
| Adlon Therapeutics L.P. | $13.59 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.